DJIA 16,563.30 -317.06 -1.88%
NASDAQ 4,369.77 -93.13 -2.09%
S&P 500 1,930.67 -39.40 -2.00%
market minute promo

Pain Therapeutics, Inc. (NASDAQ: PTIE)

4.21 -0.19 (-4.32%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PTIE $4.21 -4.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.35
Previous Close $4.40
Daily Range $3.57 - $4.35
52-Week Range $2.16 - $6.22
Market Cap $192.0M
P/E Ratio 6.98
Dividend (Yield) $0.00 (0.0%)
Volume 684,900
Average Daily Volume 408,060
Current FY EPS -$0.30

Sector

Healthcare

Industry

Drugs

Pain Therapeutics, Inc. (PTIE) Description

A biopharmaceutical company that develops novel drugs for pain management and oncology. Website: http://www.paintrials.com/

News & Commentary

AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month

Oversold Conditions For Pain Therapeutics (PTIE)

Morning Coffee: Real-Time Picks

Pain Therapeutics (PTIE) Enters Overbought Territory - Tale of the Tape

SA PRO: Top Long And Short Ideas, Thursday February 27

10 Reasons To Buy Durect Right Now

Strength Seen in Pain Therapeutics Inc. (PTIE) Stock Surges 24% - Tale of the Tape

Can Nektar Therapeutics Beat Pfizer Inc.?

In addition to Remoxy, Pfizer has an in-house formulation of abuse-resistant oxycodone in late stage trials. Could an all new opioid from Nektar Therapeutics upend both programs?

Recent News At Durect Points To Bright Future

Elite Pharmaceuticals: Swinging For The Fences

See More PTIE News...

PTIE's Top Competitors

PTIE $4.21 (-4.32%)
Current stock: PTIE
JNJ $100.09 (-2.16%)
Current stock: JNJ
NVS $86.94 (-1.70%)
Current stock: NVS
RHHBY $36.33 (-1.36%)
Current stock: RHHBY